Dr. Ryan M. Dunn, MD

Dr. Dunn practices at Intercoastal Medical Group Inc in Sarasota, Florida.

Dr. Dunn's NPI, 1114258167, was assigned on January 14, 2010. Dr. Dunn graduated from University Of Minnesota Medical School in 2009. Dr. Dunn holds Florida license ME1258668.

Dr. Dunn's primary practice is Intercoastal Medical Group Inc, at 943 S Beneva Rd, Sarasota, FL 34232 in Sarasota County. The practice phone is (941) 955-1108.

Dr. Dunn's primary practice is Intercoastal Medical Group Inc in Sarasota, Florida. Dr. Dunn is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Legacy Healthcare Services. Dmand AI also links Dr. Dunn to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dunn practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Dunn's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Dunn is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dunn's licenses on file in 3 states: Florida, Illinois and Colorado.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Dunn treats.

CMS data shows 3,717 Medicare services from Dr. Dunn across 19 procedure codes in 2024, for 1,024 Medicare patients. Medicare paid $336,107 for them.

CMS counts 1,024 Medicare patients who saw Dr. Dunn in 2024. The largest group is 75 to 84, with 424 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dunn's median patient age at 77, with 50% women.

In 2024, Dr. Dunn wrote 2,141 Medicare Part D claims for 431 patients. 45% of them were for generic drugs. CMS names the drug for 1,950 of them, across 29 drugs with 11 or more claims each, at $989,388 in total drug cost. In 2023, CMS named 1,509 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dunn for performance year 2024, reported individually. Dr. Dunn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dunn as offering telehealth.

Dmand AI links 15 papers to Dr. Dunn, published from 2011 to 2021. 2016 was the busiest year, with 2. The most frequent topics are Asthma, Adrenal Cortex Hormones and Eosinophilia. Dr. Dunn has published most often in Allergy Asthma Proc. Dr. Dunn's most frequent co-authors are Christopher David Codispoti, MD, PhD, Sima K. Ramratnam, MD and Mario Castro, MD.

Dmand AI links Dr. Dunn to 1 clinical trial. Conditions studied include Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis.

CMS Open Payments shows 87 general payments to Dr. Dunn from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $36,351.

Dr. Dunn graduated from University Of Minnesota Medical School in 2009.

Dr. Dunn is in network with 16 carriers, including Elevance, Aetna and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.